A phase 3 randomized study investigating the FLT3 inhibitor Sorafenib in sequence after intensive chemotherapy for untreated adult AML harboring FLT3 mutations

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1131/12/13

Funding

  • Leukaemia Foundation: AUD599,500.50